Form 4: Astera Labs COO Sanjay Gajendra Sells $9.8M in Stock

Astera Labs President and COO Sanjay Gajendra executed a series of planned stock sales totaling over 49,000 shares through estate planning trusts.

Summary

• Sanjay Gajendra, President and COO of Astera Labs, sold a total of 49,361 shares of common stock on May 7, 2026.
• The transactions were executed in multiple tranches at weighted average prices ranging from $193.01 to $213.49 per share.
• The total proceeds from the sales are estimated at approximately $9.87 million.
• The sales were conducted under a Rule 10b5-1 trading plan, which was previously adopted on December 2, 2025.
• Following these transactions, Gajendra continues to hold a significant stake of 2,841,301 shares across direct and indirect holdings.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative event. While the dollar amount is high, the sale was pre-planned and the executive remains heavily invested in the company's success.

Positives

• The sales were made pursuant to a Rule 10b5-1 trading plan, providing an affirmative defense against accusations of trading on non-public information.
• The reporting person retains a very substantial ownership position of over 2.8 million shares, maintaining significant skin in the game.
• The transactions appear to be part of routine estate planning rather than an emergency liquidation.

Negatives

• Large-scale insider selling can sometimes be interpreted by the market as a signal that management believes the stock is reaching a valuation ceiling.
• The sale of nearly 50,000 shares represents a notable reduction in the specific trust-held portions of the executive's portfolio.

Risks

• Potential for negative market sentiment if investors perceive the volume of selling as a lack of confidence in near-term upside.
• Reliance on automated trading plans can lead to sales during periods of market weakness if price triggers are met.

Future Outlook

The use of a Rule 10b5-1 plan suggests that further automated sales may occur in the future as part of the executive's long-term financial and estate planning strategy.

Management Comments

• The reporting person disclaims beneficial ownership of the securities held in the estate planning trusts except to the extent of his pecuniary interest.

Industry Context

StockSavvy.ai notes that in the high-growth semiconductor sector, it is standard practice for founders and C-suite executives to diversify their wealth through pre-arranged trading plans, especially following significant stock price appreciation.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the gold standard for executive transparency in the U.S. technology sector.
• The volume of the sale relative to total holdings (less than 2%) is consistent with conservative diversification strategies seen at peer companies like Nvidia or Marvell.

Related Party Transactions

• The transactions involved shares held by estate planning trusts (Trust 2 and Trust 3) for which the reporting person is a beneficiary or trustee.

Stakeholder Impact

• Shareholders may monitor these sales as a gauge of insider sentiment, though the planned nature of the sale mitigates immediate concern.
• The company's capital structure remains stable as these are secondary market transactions.

Next Steps

• Monitor future Form 4 filings to determine if other executives are also selling under similar plans.
• Track the stock price performance relative to the weighted average sale prices of approximately $200.

Key Dates

Recommendation

The filing indicates routine, planned diversification by a key executive rather than a fundamental shift in company prospects. Investors should maintain their current positions while monitoring broader semiconductor market trends.

Keywords

Astera Labs, ALAB, Sanjay Gajendra, Insider Selling, Form 4, Rule 10b5-1, Semiconductor, Connectivity Solutions, Executive Compensation